vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and MetroCity Bankshares, Inc. (MCBS). Click either name above to swap in a different company.

MetroCity Bankshares, Inc. is the larger business by last-quarter revenue ($43.7M vs $23.1M, roughly 1.9× ADC Therapeutics SA). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs 23.6%). Over the past eight quarters, MetroCity Bankshares, Inc.'s revenue compounded faster (15.7% CAGR vs 13.7%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

Metro City Bank is a Korean-American bank based in Doraville, Georgia and offers personal and commercial banking services. It is the largest Korean-American bank to not be based out of Los Angeles, California. It currently operates a total of 19 branches in Texas, New York, New Jersey, Virginia, Georgia, Alabama, and Florida.

ADCT vs MCBS — Head-to-Head

Bigger by revenue
MCBS
MCBS
1.9× larger
MCBS
$43.7M
$23.1M
ADCT
Growing faster (revenue YoY)
ADCT
ADCT
+12.7% gap
ADCT
36.4%
23.6%
MCBS
Faster 2-yr revenue CAGR
MCBS
MCBS
Annualised
MCBS
15.7%
13.7%
ADCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADCT
ADCT
MCBS
MCBS
Revenue
$23.1M
$43.7M
Net Profit
$18.1M
Gross Margin
Operating Margin
-77.7%
52.8%
Net Margin
50.5%
Revenue YoY
36.4%
23.6%
Net Profit YoY
11.7%
EPS (diluted)
$0.04
$0.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
MCBS
MCBS
Q4 25
$23.1M
$43.7M
Q3 25
$15.8M
$38.0M
Q2 25
$18.1M
$37.9M
Q1 25
$17.4M
$36.0M
Q4 24
$16.9M
$35.4M
Q3 24
$18.0M
$36.9M
Q2 24
$17.0M
$36.3M
Q1 24
$17.8M
$32.7M
Net Profit
ADCT
ADCT
MCBS
MCBS
Q4 25
$18.1M
Q3 25
$-41.0M
$17.3M
Q2 25
$-56.6M
$16.8M
Q1 25
$-38.6M
$16.3M
Q4 24
$16.2M
Q3 24
$-44.0M
$16.7M
Q2 24
$-36.5M
$16.9M
Q1 24
$-46.6M
$14.6M
Operating Margin
ADCT
ADCT
MCBS
MCBS
Q4 25
-77.7%
52.8%
Q3 25
-196.6%
62.8%
Q2 25
-244.1%
62.4%
Q1 25
-163.5%
61.3%
Q4 24
-191.8%
58.9%
Q3 24
-197.4%
61.4%
Q2 24
-170.5%
64.4%
Q1 24
-188.3%
62.6%
Net Margin
ADCT
ADCT
MCBS
MCBS
Q4 25
50.5%
Q3 25
-260.1%
45.5%
Q2 25
-313.2%
44.4%
Q1 25
-221.8%
45.3%
Q4 24
54.0%
Q3 24
-244.1%
45.3%
Q2 24
-214.6%
46.7%
Q1 24
-261.1%
44.8%
EPS (diluted)
ADCT
ADCT
MCBS
MCBS
Q4 25
$0.04
$0.69
Q3 25
$-0.30
$0.67
Q2 25
$-0.50
$0.65
Q1 25
$-0.36
$0.63
Q4 24
$-0.26
$0.64
Q3 24
$-0.42
$0.65
Q2 24
$-0.38
$0.66
Q1 24
$-0.56
$0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
MCBS
MCBS
Cash + ST InvestmentsLiquidity on hand
$261.3M
$383.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$544.2M
Total Assets
$323.1M
$4.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
MCBS
MCBS
Q4 25
$261.3M
$383.7M
Q3 25
$234.7M
$227.2M
Q2 25
$264.6M
$286.0M
Q1 25
$194.7M
$285.1M
Q4 24
$250.9M
$249.9M
Q3 24
$274.3M
$291.2M
Q2 24
$300.1M
$327.9M
Q1 24
$234.3M
$258.8M
Stockholders' Equity
ADCT
ADCT
MCBS
MCBS
Q4 25
$-185.8M
$544.2M
Q3 25
$-238.2M
$445.9M
Q2 25
$-199.2M
$436.1M
Q1 25
$-238.2M
$428.0M
Q4 24
$-202.6M
$421.4M
Q3 24
$-171.9M
$407.2M
Q2 24
$-131.7M
$407.2M
Q1 24
$-194.4M
$396.6M
Total Assets
ADCT
ADCT
MCBS
MCBS
Q4 25
$323.1M
$4.8B
Q3 25
$289.8M
$3.6B
Q2 25
$321.6M
$3.6B
Q1 25
$272.5M
$3.7B
Q4 24
$322.0M
$3.6B
Q3 24
$349.1M
$3.6B
Q2 24
$371.8M
$3.6B
Q1 24
$308.0M
$3.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
MCBS
MCBS
Operating Cash FlowLast quarter
$-31.1M
$37.7M
Free Cash FlowOCF − Capex
$37.0M
FCF MarginFCF / Revenue
84.7%
Capex IntensityCapex / Revenue
0.0%
1.5%
Cash ConversionOCF / Net Profit
2.08×
TTM Free Cash FlowTrailing 4 quarters
$79.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
MCBS
MCBS
Q4 25
$-31.1M
$37.7M
Q3 25
$-29.6M
$16.5M
Q2 25
$-24.1M
$14.5M
Q1 25
$-56.3M
$11.9M
Q4 24
$-21.9M
$63.5M
Q3 24
$-25.0M
$-11.5M
Q2 24
$-32.8M
$19.4M
Q1 24
$-44.1M
$36.4M
Free Cash Flow
ADCT
ADCT
MCBS
MCBS
Q4 25
$37.0M
Q3 25
$16.2M
Q2 25
$14.3M
Q1 25
$-56.6M
$11.8M
Q4 24
$-21.9M
$62.2M
Q3 24
$-25.3M
$-11.8M
Q2 24
$-32.9M
$19.0M
Q1 24
$-44.6M
$36.1M
FCF Margin
ADCT
ADCT
MCBS
MCBS
Q4 25
84.7%
Q3 25
42.7%
Q2 25
37.8%
Q1 25
-325.2%
32.9%
Q4 24
-129.8%
175.8%
Q3 24
-140.2%
-31.9%
Q2 24
-193.0%
52.4%
Q1 24
-250.0%
110.6%
Capex Intensity
ADCT
ADCT
MCBS
MCBS
Q4 25
0.0%
1.5%
Q3 25
0.0%
0.7%
Q2 25
0.0%
0.3%
Q1 25
1.5%
0.2%
Q4 24
0.5%
3.6%
Q3 24
1.2%
0.8%
Q2 24
0.2%
1.0%
Q1 24
3.0%
0.7%
Cash Conversion
ADCT
ADCT
MCBS
MCBS
Q4 25
2.08×
Q3 25
0.95×
Q2 25
0.86×
Q1 25
0.73×
Q4 24
3.91×
Q3 24
-0.69×
Q2 24
1.14×
Q1 24
2.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons